I am a psychiatrist and neuroscientist focused on translational neuroscience research. My lab’s overall goal is to implement image-guided transcranial focused ultrasound (FUS) technologies to rebalance synaptic stability and plasticity in the brain, as a treatment for disorders of excessive neural circuit stability including autism, OCD, Tourette, addiction, and PTSD. FUS has high spatial resolution (up to ~1 mm) that can be shaped to the target structure, can modulate neural activity through its impact on mechanosensitive ion channels, and can target biopharmaceuticals into the brain. My lab is currently advancing early-stage in-human studies using the visual system as a test-bed to optimize FUS neuromodulation, and we are organizing early-stage FUS clinical trials to ameliorate insistence on sameness symptoms in autism. Moreover, in preclinical models we use FUS-targeted biopharmaceuticals to modulate synaptic stability and normalize behavioral inflexibility in psychiatric disorders, in tandem with radiotracer-conjugated engineered antibodies to quantify synaptic stability with immuno-PET/SPECT. This work is among the first attempts to pursue theranostics-inspired approaches for plasticity-rebalancing treatment in severe psychiatric illness. I have a K08 career development award, a SFARI Fellows-to-Faculty award, Deeda Blair Initiative award, BBRF Young Investigator award, and start-up funds to support these projects. I have more than a year of silent retreat experience in the Vipassana meditation tradition. My clinical practice specialization is in functional neurological disorder, and I am interested in implementing psychedelic psychotherapy in this patient population.